Article Text

Download PDFPDF

129 Impact of Cardiovascular Magnetic Resonance on Management and Clinical Decision-Making in Acute Hospitalised Patients
  1. Estefania De Garate,
  2. Amardeep Ghosh Dastidar,
  3. Anna Baritussio,
  4. Alessandra Scatteia,
  5. Antonio Amadu,
  6. Giuseppe Venuti,
  7. Jonathan C Rodrigues,
  8. Chiara Bucciarelli-Ducci
  1. NIHR Bristol Cardiovascular Biomedical Research Unit, Bristol Heart Institute, Bristol, Avon, UK


Background Cardiac Magnetic Resonance (CMR) is a valuable tool in the assessment of both ischaemic and non-ischaemic heart disease. The use of CMR in chronic cardiac conditions has already been demonstrated. However, evidence of the impact of CMR on the clinical management on the acute phase of hospital care, is scarce. We sought to evaluate the impact of CMR on diagnosis and clinical decision-making in acute hospitalised patients.

Methods We looked at the 1 year registry data of 2481 consecutive scans (Jan 2014-Dec2014) at a large tertiary cardiothoracic center and identified 283 patients refered for inpatient CMR scan. CMR protocol included short axis and long axis cines, T2 weighted oedema sequences, early and late gadolinium enhancement (LGE) images. Definitions for “significant clinical impact” of CMR were pre-defined and data was collected from clinical records. Categories of significant clinical impact included change in pre-CMR diagnosis, influence on hospitalization period, change in medication, as well as influence on invasive medical procedures such as CABG, angiography and ICD implantation.

Results Of the 283 patients, 8 (2.8%) were excluded due to poor image quality and/or incomplete scans, leaving a sample of 275 patients (66% male, mean age 59yrs) with mean ejection fraction of 46%+-19.

Overall, CMR had a significant clinical impact on 68% of the patients. This included a completely new diagnosis in 27% of the patients, change in management in 31% and a total of 10% of patients had both a new diagnosis and a change in management (see Figure 2). CMR results led to invasive procedures on 27%, avoided invasive procedures on 16%, and had an influence on hospital discharge on 15% of the patients. 84% of the patients had echocardiography prior to CMR. CMR confirmed the echo diagnosis in 11%, complemented the echo findings by additing significant new information in 41% and changed the diagnosis made on echo in 30% of the cases.

In a multivariable model that included clinical and imaging parameters, age and presence of LGE were the only independent predictor of “significant clinical impact” (LGE p-value. 007, OR 2.782, CI 1.328–5.828) (see Figure 1).

Abstract 129 Figure 1

(A) Change in diagnosis after CMR in patients with chest pain; (B) Change in diagnosis after CMR in patients with shortness of breath; (C) Change in diagnosis after CMR in patients with syncope, arrhythmias and out of hospital cardiac arrest

Conclusions CMR had a significant clinical impact on both management and diagnosis in 68% of acutely hospitalised patients. The presence of LGE was the best independent predictor of significant clinical impact following CMR.

Abstract 129 Table 1
  • cardiac magnetic resonance
  • clinical impact
  • hospitalised patients

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.